To observe the effect of Shenlong Oral Liquid（SLOL）combined with radiotherapy in treating nasopharyngeal carcinoma (NPC). Methods: Effects of the combined therapy, including clinical effects, changes of cellular immunity and side effects, in treating 60 NPC patients (in the treated group) were observed and compared with those of the other 60 patients treated with radiotherapy alone (in the control group). Results: (1)The side effects of radiation in the treated group were lower than those in the control group significantly (P＜0.05). (2) The short-term remission rate of nasopharyngeal and neck metastatic tumor in the two groups was not significantly different (P＞0.05). (3) The dose for complete remission of nasopharyngeal and neck tumor in the treated group was lower than that in the control group (P<0.01). (4) No change of T-lymphocyte subsets was found in the treated group after treatment, but in the control group , OKT3,OKT4,and OKT4/OKT8 ratio were markedly decreased (P＜0.05). (5) The survival rate in the treated group was higher than that in the control group, but with no statistical significance (P=0.0518). Conclusion: The combined therapy of NPC with SLOL and radiotherapy is able to reduce side-effect of radiotherapy, improve the cellular immunity, reduce the dose of radiation for tumor remission and enhance the therapeutic effect of radiotherapy. It showed a trend of raising the long-term survival rate of NPC patients.

Objective: To evaluate the effect of Chinese herbal medicine (CHM) in the process of corticosterone (CS) reduction in nephrotic syndrome. Methods: One hundred and twenty patients of idiopathic nephrotic syndrome sensitive to prednisone treatment were divided into two groups randomly. The dosage of prednisone used was conventionally reduced in both groups but CHM herbal treatment was added to the treated group in the period of prednisone reduction. The effect of CHM was estimated by observing the recurrence rate of disease and side-effects of prednisone. Results: The recurrence rate of disease and the occurrence rate of side-effects of prednisone in the treated group were less than those in the control group significantly (P<0.01). Conclusion: Additional CHM in the process of CS reduction in treating CS sensitive nephrotic syndrome could markedly abate the recurrence rate of disease and the side-effect of CS reduction.

Objective: To evaluate the effect of Chinese herbal medicine (CHM) in the process of corticosterone (CS) reduction in nephrotic syndrome. Methods: One hundred and twenty patients of idiopathic nephrotic syndrome sensitive to prednisone treatment were divided into two groups randomly. The dosage of prednisone used was conventionally reduced in both groups but CHM herbal treatment was added to the treated group in the period of prednisone reduction. The effect of CHM was estimated by observing the recurrence rate of disease and side-effects of prednisone. Results: The recurrence rate of disease and the occurrence rate of side-effects of prednisone in the treated group were less than those in the control group significantly (P<0.01). Conclusion: Additional CHM in the process of CS reduction in treating CS sensitive nephrotic syndrome could markedly abate the recurrence rate of disease and the side-effect of CS reduction.

To study the therapeutic effect of Chinese herbal medicine (CHM) combined with bronchial arterial chemotherapy (BAC) in treating lung cancer.Methods: Ninety patients with mid-advanced non-small cell lung cancer (NSCLC) were randomly divided into two groups. The 45 cases in Group A were treated with CHM combined with BAC and the 45 cases in Group B treated with BAC alone. The short-term and long-term effect, follow-up survival rate, quality of life, changes of clinical symptoms and peripheral blood figures in the patients were observed.Results: After treatment, the rate of CR+PR+NC in the two groups was 88.89% and 68.89% respectively, the inter-group comparison showed a significant difference (P<0.05). The 0.5-, 1- and 2-year survival rate in Group A was 75.56%, 55.56% and 48.89% respectively and in Group B 71.11%, 46.67% and 24.44% respectively. The 2-year survival rate in the former was better than that in the latter (P<0.05). Moreover, the improvement of clinical symptoms, Karnofsky scoring, body weight and peripheral blood figure in Group A was superior to those in Group B.Conclusion: Therapeutic effect of BAC could be enhanced by combining it with CHM.

Objective: To evaluate the therapeutic effect of Yangxin Fumai Oral Liquid (YFOL,养心复脉口服液), a Chinese herbal medicine for nourishing Heart and restoring pulse, in treating patients with extrasystole. Methods: The effect of YFOL was observed in treating 30 patients with different kinds of extrasystole and compared with that in 30 patients treated by propafenone. The effect of YFOL on experimental arrhythmia was studied in animals as well. Results: Clinical observation showed that the effect of treatment against extrasystole in the two groups was similar, but the YFOL group showed better results in symptom improvement (P<0.01) with no marked side-effect. Experimental study showed that YFOL could reduce the chloroform induced ventricular fibrillation occurrence in mice, delay the initiating time of ventricular extrasystole, tachycardia and fibrillation induced by aconitine, BaCl2 and coronary artery ligation in rats, or shorten the lasting time of arrhythmia, reduce the attacking frequency of ventricular extrasystole. There was significant difference in comparing with the control group (P<0.05, P<0.01). Conclusion:YFOL is a good and convenient Chinese herbal preparation for different kinds of extrasystole with few toxic and side-effect in clinical practice.

Objective: To evaluate the effectiveness, toxicity and prospective application of hepatic arterial infusion (HAI) with embolized Curcuma Aromatic oil (CAO) in treating primary liver cancer (PLC). Methods: In the treated group, 32 patients with PLC were treated by HAI with 1-3 ml embolized CAO and oral administration of Chinese herbal medicine. In the control group, 32 patients with PLC were treated with transcatheter artery chemoembolization (TACE). Results: In the treated group, one patient attained complete remission (CR) and 13 partial remission (PR), the total effective rate being 43.75%. The level of alpha fetal protein (AFP) turned to normal range in 7 cases and decreased in other 7. In the control group, 10 obtained PR and the total effective rate being 31.25%, AFP level turned to normal in 5 and decreased in 2. There was no statistical significance between the two groups. The incidences of post-embolism Sydrome, such as fever, abdominal pain and vomiting were similar between the two groups but no myelosuppression occurred in the treated group with significant difference as comparing with that in the control group (P<0.01). The mean survival time, median survival time, 1-, 2- and 3-year survival rate in the treated group were 11.5 months, 10 months, 37.5%, 13.3% and 6.9% respectively, while in the control group they were 7.25 months, 6 months, 15.6%, 3.2% and 0% respectively. Better result in mean survival time, median survival time and 1-year survival rate was found in the treated group than that of the control group (P<0.05). Conclusion:HAI with embolized CAO showed a similar good effect in treating PLC as that of TACE, but superior to TACE with longer survival time and milder myelosuppression.

In recent ten-odd years the pathogenetic regulation of female idiopathic precocious puberty was studied in our hospital, in terms of the function of hypothalamic-pituitary-gonadal axis (HPG axis) and the status of skeletal development as indicators. The therapy with Chinese herbal medicine (CHM) in predominance was formulated, according to our understanding of the regulation and Syndrome Differentiation of traditional Chinese medicine (TCM). It has been clinically verified that the therapy could successfully modulate the course of pubertal development and optimize skeletal development in children with precocious puberty. The mechanism of effectiveness of the drugs has been further studied focusing on the neuroendocrine regulation and gene expression with modern medical techniques.

中药防治脑缺血再灌注损伤的研究

现代医学研究认为缺血再灌注损伤是大多数缺血性脑血管病的主要的病理生理过程,其发生机制主要有自由基学说、钙超载学说、兴奋性氨基酸学说、花生四烯酸代谢失衡和白细胞损伤作用等.中医将本病归属中风范畴,病机为气虚不能帅血,或气滞血瘀阻滞脉络所致,是临床常见的预后较差的一种疾病,因而如何防止脑缺血损伤引起国内外广泛重视.近年来的研究表明,许多中药有抗脑缺血再灌注损伤的作用.本文就中药防治脑缺血再灌注的研究状况作一综述.1 清除自由基人体正常代谢产生的自由基可被体内相应的自由基清除酶如超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)等及时清除,使自由基产生与清除之间处于动态平衡.脑缺血再灌注时,可通过黄嘌呤氧化酶、线粒体系统、白细胞系统、花生四烯酸相关酶系统、一氧化氮合成酶系统等使氧自由基(OFR)大量产生,同时OFR防御系统功能受损,动态平衡被破坏.自由基具有很高的化学活性,可通过OFR连锁反应造成膜损伤、线粒体功能障碍、溶酶体破裂、细胞溶解和组织水肿等一系列损害,故氧自由基学说在脑缺血再灌注损伤机理中占有重要地位.

中药配合放射治疗鼻咽癌的研究进展

鼻咽癌是我国常见的恶性肿瘤之一，在治疗上目前仍是放疗为主，取得较好的效果，但也产生了一系列放疗副作用及后遗症。不少学者以传统的中医理论和现代医学方法相结合进行了临床研究，颇有成效。现就几年来中药配合放疗鼻咽癌作一综述。 1 单味中药配合放射治疗鼻咽癌国内学者认为放射线属于火热毒邪，作用于人体导致热毒过盛，日久热毒伤津耗气，脾肾受损。治法多为清热解毒、滋阴生津、活血化瘀、健脾益肾等法，与之相应的使用药物大致分为清热、活血及补益药三大类。

肝星状细胞中药血清药理学实验研究概况

中药血清药理学研究方法是针对中药及其复方复杂多样的化学成分特点,用含药血清代替煎剂或粗提物进行实验研究的新方法,其可信性和科学性更强.肝星状细胞(hepatic stellate cell, HSC)在肝纤维化病理过程中起着十分关键的作用[1],近年来,国内学者采用中药血清药理学研究方法对肝星状细胞进行了大量的实验研究,现综述如下.

中药配合介入及放射疗法治疗非小细胞肺癌的临床观察

非小细胞肺癌(nonsmall cell lung cancer, NSCLC)大约占全部肺癌发病率的75%左右,晚期非小细胞肺癌的治疗,目前缺少有效的治疗手段,所以治疗的主要目的是缓解症状,减轻患者痛苦,提高生存质量及延长生存期.我院自1997年3月-2002年5月开展了介入治疗联合放射疗法(放疗)同时结合中药辨证治疗晚期NSCLC,取得一定疗效,现报告如下.

中草药治疗慢性乙型肝炎随机对照试验的系统评价

乙型肝炎是由乙型肝炎病毒(HBV)引起的传染性肝病.全世界已有20多亿人口被感染,约3亿5千万人成为慢性HBV感染者(1,2).慢性携带者易于发生肝硬化与肝癌,全世界每年有100余万患者死于肝病(1),其中1/3在中国(3).

谈中药药性理论有关术语的英译

中药药性理论的内容,包括四气、五味、升降浮沉和归经等.它是古代医家在长期的医疗实践中对药物作用的认识,其中四气、五味因来自于自然界的气化,故以"司岁备物"(<素问·至真要大论>)之运气理论作指导.中药药性理论有关术语的英译应忠实于此事实,现分述如下.

Pointed condyloma in the anus is caused by a virus of human papilloma, marked by the presence of rapidly growing cutaneous verrucae with itching, mild pain and offensive secretion. Diagnosis can be made based on biopsy. The disease is of high recurrence and very difficult to be cured radically. The author combined surgery with external washing with Chinese herbal medicine and achieved quite good results. The following is report of the treatment.

Since 1995, the Chinese herbal medicine for supplementing qi and activating blood circulation combined with injection of ahylsantinfarctase into the femoral artery has been used in 28 cases of diabetes complicated with gangrene and ulcer of the foot, with quite good therapeutic effects as reported in the following.

Since 1995, the Chinese herbal medicine for supplementing qi and activating blood circulation combined with injection of ahylsantinfarctase into the femoral artery has been used in 28 cases of diabetes complicated with gangrene and ulcer of the foot, with quite good therapeutic effects as reported in the following.

Under the guidance of family veteran Chinese physicians, the author has been pursuing the research and treatment of mental diseases with Chinese herbal medicine supplemented by acupuncture and moxibustion with satisfactory therapeutic effects which is introduced as follows.

复方中药99-克星超声介入治疗肝癌裸鼠移植瘤凋亡与增生

目的:探讨超声引导瘤内注射复方中药99-克星治疗肝癌SMMC-7721裸鼠移植瘤的抗癌作用.方法:取人肝癌SMMC-7721裸鼠皮下移植模型28只,随机分为99-克星中药治疗组14只,无水乙醇与生理盐水治疗组各7只.全部裸鼠在接种10 d后每隔5 d向肿瘤内注入治疗药物共4次,治疗20 d后处死.应用免疫组织化学方法检测移植瘤细胞Ki-67抗原的表达并行流式细胞仪(FCM)DNA分析以及采用TUNEL方法对移植瘤细胞凋亡现象进行观察.结果:中药99克星组与乙醇组的Ki-67指数分别为17±9%、21±11%,均显著低于盐水组的32±13%(P＜0.05);克星组凋亡指数高达49±5%,显著高于乙醇组的12±2%和盐水组的10±4%(均P<0.01);FCM DNA分析显示盐水组的异倍体峰出现率高达57%,明显高于克星组的7%与乙醇组的0%(P均<0.05),而克星组的凋亡峰出现率高达93%,明显高于乙醇组的14%与盐水组的0%(P均<0.01).结论:复方中药99克星能显著抑制裸鼠移植瘤细胞的增生,并诱发其凋亡.研究结果表明复方中药99克星具有强大的破坏与抑制肿瘤细胞生长的作用,其疗效不亚于无水乙醇,其主要机制可能有:(1)抑制癌细胞的增生,(2)诱导癌细胞凋亡.复方中药99-克星抗肿瘤的作用机制不同于无水乙醇,尤其以抑制癌细胞增生和诱导癌细胞凋亡的作用机制在抗肿瘤中具有重要的意义.本研究为传统中药治疗肝癌提供了一个新的给药途径与理论依据,其在肿瘤治疗研究中具有重要的意义和良好的发展前景.

猫甲少腹逐瘀汤治疗慢性附睾炎56例

笔者几年来应用猫甲少腹逐瘀汤加减治疗慢性附睾炎56例,取得良好疗效,现介绍如下.1 一般资料本组56例慢性附睾炎患者均为门诊病人,多为中青年人群,年龄25～55岁.其中25～35岁23例,35～45岁20例,45～55岁13例.病程2个月至2年.